KANGIO (BIVALIRUDIN) INJECTION
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

KANGIO (BIVALIRUDIN) INJECTION Trademark

Serial Number: 86851093

KANGIO (BIVALIRUDIN) INJECTION is a trademark filed by Eagle Pharmaceuticals, Inc. on December 16, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Eagle Pharmaceuticals, Inc. (30 trademarks)

50 Tice Boulevard, Suite 315
Woodcliff Lake, NJ 07677

Entity Type: 03

Trademark Details

Filing Date

December 16, 2015

Registration Date

Not Registered

Published for Opposition

May 31, 2016

Goods & Services

BIVALIRUDIN PREPARATIONS FOR PHARMACEUTICAL PURPOSES

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Apr 27, 2026 ASCK
ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Aug 4, 2016 MAB5
ABANDONMENT - AFTER PUBLICATION
Aug 4, 2016 ABN5
WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Jul 18, 2016 ISPO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 31, 2016 NPUB
PUBLISHED FOR OPPOSITION
May 31, 2016 PUBO
TEAS EXPRESS ABANDONMENT RECEIVED
May 23, 2016 EXAR
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 11, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 28, 2016 PREV
ASSIGNED TO LIE
Apr 21, 2016 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 9, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 8, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 8, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 8, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 3, 2016 GNRN
NON-FINAL ACTION E-MAILED
Apr 3, 2016 GNRT
NON-FINAL ACTION WRITTEN
Apr 3, 2016 CNRT
ASSIGNED TO EXAMINER
Apr 2, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 22, 2015 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 21, 2015 NWOS
NEW APPLICATION ENTERED
Dec 19, 2015 NWAP